tiprankstipranks

Craig Collard Insider Profile

4 Followers
Craig Collard, CEO, Director at Heron Therapeutics, holds 856.49K shares in Heron Therapeutics (Ticker: HRTX), holds 0.00 shares in Opiant Pharmaceuticals (Ticker: OPNT), holds 0.00 shares in Sierra Oncology (Ticker: SRRA).
tipranks
Craig Collard

Craig Collard
Heron Therapeutics (HRTX)
CEO, Director

Ranked #83,603 out of 108,921 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

-26.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$300K
100.00%
A breakdown of Craig Collard's holdings

Insider Roles

Heron Therapeutics
(HRTX)
CEO, Director
Roles that Craig Collard holds in companies

Most Profitable Insider Trade

Stock:
Heron Therapeutics
(HRTX)
Rating:Informative Buy
Date:Nov 17, 2023 - Nov 17, 2024
Return:+9.10%
The most profitable trade made by Craig Collard

Craig Collard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Heron Therapeutics
Aug 03, 2026
CEO, Director
Uninformative Buy
42.12K
$299.77K
~CRTX
Cornerstone Therapeutics Inc
Feb 04, 2014
Uninformative Sell
427.50K
OPNT
Opiant Pharmaceuticals
Mar 03, 2023
Uninformative Sell
1.08M
$0.00
SRRA
Sierra Oncology
Jul 01, 2022
Uninformative Sell
742.50K
$0.00
List of latest transactions for each holding click on a transaction to see Craig Collard's performance on stock

Craig Collard insider profile FAQ

What is the percentage of profitable transactions made by Craig Collard?
The percentage of profitable transactions made by Craig Collard is 33%.
    What is the average return per transaction made by Craig Collard?
    The average return per transaction made by Craig Collard is -26.10%.
      What stocks does Craig Collard hold?
      Craig Collard holds: HRTX, ~CRTX, OPNT, SRRA stocks.
        What was Craig Collard’s latest transaction?
        Craig Collard latest transaction was an Uninformative Buy of $42.12K.
          What was Craig Collard's most profitable transaction?
          Craig Collard’s most profitable transaction was an Informative Buy of HRTX stock on November 17, 2023. The return on the trade was 9.10%.
            What is Craig Collard's role in Heron Therapeutics?
            Craig Collard's role in Heron Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.